Literature DB >> 32164061

[Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)].

.   

Abstract

Entities:  

Keywords:  Carcinoma, hepatocellular; Diagnosis; Guidelines; Therapeutics

Year:  2020        PMID： 32164061     DOI： 10.3760/cma.j.issn.1007-3418.2020.02.004

Source DB:  PubMed          Journal:  Zhonghua Gan Zang Bing Za Zhi        ISSN： 1007-3418


× No keyword cloud information.
  45 in total

Review 1.  Interpretation of guidelines for the diagnosis and treatment of primary liver cancer (2019 edition) in China.

Authors:  Guoteng Qiu; Zhaoxing Jin; Xin Chen; Jiwei Huang
Journal:  Glob Health Med       Date:  2020-10-31

2.  Prognostic significance of controlling nutritional status score-based nomogram for hepatocellular carcinoma within Milan criteria after radiofrequency ablation.

Authors:  Yi Yang; Feng Ye; Yujing Xin; Yanan Wang; Xiao Li; Duiping Feng; Yi Chen; Xiang Zhou
Journal:  J Gastrointest Oncol       Date:  2020-10

Review 3.  2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights.

Authors:  Di-Yang Xie; Zheng-Gang Ren; Jian Zhou; Jia Fan; Qiang Gao
Journal:  Hepatobiliary Surg Nutr       Date:  2020-08       Impact factor: 7.293

4.  CalliSpheres® microspheres drug-eluting bead transhepatic artery chemoembolization with or without sorafenib for the treatment of large liver cancer: a multi-center retrospective study.

Authors:  Song Liu; Guangji Yu; Qingdong Wang; Long Li; Ying Liu; Ke Du; Fei Zhang; Bangli Zhao; Guangsheng Zhao
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

5.  Outcomes and recurrence patterns following curative hepatectomy for hepatocellular carcinoma patients with different China liver cancer staging.

Authors:  Changxian Li; Hongwei Wang; Ruixiang Chen; Hui Zhang; Yonghua Xu; Bin Zhang; Yong Li; Changhe Zhang; Yue Yang; Xuehao Wang; Xiangcheng Li
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

6.  Prognostic significance of systemic immune-inflammation index-based nomogram for early stage hepatocellular carcinoma after radiofrequency ablation.

Authors:  Yujing Xin; Yi Yang; Ning Liu; Yi Chen; Yanan Wang; Xinyuan Zhang; Xiao Li; Xiang Zhou
Journal:  J Gastrointest Oncol       Date:  2021-04

7.  Prediction of Hepatocellular Carcinoma Response to Transcatheter Arterial Chemoembolization: A Real-World Study Based on Non-Contrast Computed Tomography Radiomics and General Image Features.

Authors:  Zheng Guo; Nanying Zhong; Xueming Xu; Yu Zhang; Xiaoning Luo; Huabin Zhu; Xiufang Zhang; Di Wu; Yingwei Qiu; Fuping Tu
Journal:  J Hepatocell Carcinoma       Date:  2021-07-09

8.  Selection of first-line systemic therapies for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials.

Authors:  Yue Han; Wei-Hua Zhi; Fei Xu; Chen-Bo Zhang; Xiao-Qian Huang; Jian-Feng Luo
Journal:  World J Gastroenterol       Date:  2021-05-21       Impact factor: 5.742

9.  An evaluation of the reporting quality in clinical practice guidelines for hepatocellular carcinoma using the RIGHT checklist.

Authors:  Haiyang Chen; Meng Tao; Ding Li; Jing Han; Cheng Cheng; Yanfang Ma; Yingxi Wu; Vishal G Shelat; Francisco Tustumi; Sanjaya K Satapathy; Koo Jeong Kang; Qiming Wang
Journal:  Ann Transl Med       Date:  2021-06

10.  Determining the Traditional Chinese Medicine (TCM) Syndrome with the Best Prognosis of HBV-Related HCC and Exploring the Related Mechanism Using Network Pharmacology.

Authors:  Zhulin Wu; Chunshan Wei; Lianan Wang; Li He
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-29       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.